Laboratorios Farmaceuticos ROVI SA
OTC:LABFF
Wall Street
Price Targets
LABFF Price Targets Summary
Laboratorios Farmaceuticos ROVI SA
According to Wall Street analysts, the average 1-year price target for
LABFF
is 86.12 USD
with a low forecast of 67.36 USD and a high forecast of 110.35 USD.
Price Targets
Operating Income
Forecast
Operating Income Estimate
Laboratorios Farmaceuticos ROVI SA
For the last 8 years the
compound annual growth rate for
Laboratorios Farmaceuticos ROVI SA's operating income is
33%.
The projected
CAGR
for the next 3 years is
14%.
Net Income
Forecast
Net Income Estimate
Laboratorios Farmaceuticos ROVI SA
For the last 8 years the
compound annual growth rate for
Laboratorios Farmaceuticos ROVI SA's net income is
31%.
The projected
CAGR
for the next 3 years is
17%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is LABFF's stock price target?
Price Target
86.12
USD
According to Wall Street analysts, the average 1-year price target for
LABFF
is 86.12 USD
with a low forecast of 67.36 USD and a high forecast of 110.35 USD.
What is Laboratorios Farmaceuticos ROVI SA's Revenue forecast?
Projected CAGR
8%
For the last 8 years the
compound annual growth rate for
Laboratorios Farmaceuticos ROVI SA's revenue is
16%.
The projected
CAGR
for the next 3 years is
8%.
What is Laboratorios Farmaceuticos ROVI SA's Operating Income forecast?
Projected CAGR
14%
For the last 8 years the
compound annual growth rate for
Laboratorios Farmaceuticos ROVI SA's operating income is
33%.
The projected
CAGR
for the next 3 years is
14%.
What is Laboratorios Farmaceuticos ROVI SA's Net Income forecast?
Projected CAGR
17%
For the last 8 years the
compound annual growth rate for
Laboratorios Farmaceuticos ROVI SA's net income is
31%.
The projected
CAGR
for the next 3 years is
17%.
You don't have any saved screeners yet
